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Abstract
Control of host cell death is of paramount importance for the survival and replication of obligate intracellular bacteria.
Among these, human pathogenic Chlamydia induces the inhibition of apoptosis in a variety of different host cells by directly
interfering with cell death signaling. However, the evolutionary conservation of cell death regulation has not been
investigated in the order Chlamydiales, which also includes Chlamydia-like organisms with a broader host spectrum. Here,
we investigated the apoptotic response of human cells infected with the Chlamydia-like organism Simkania negevensis (Sn).
Simkania infected cells exhibited strong resistance to apoptosis induced by intrinsic stress or by the activation of cell death
receptors. Apoptotic signaling was blocked upstream of mitochondria since Bax translocation, Bax and Bak oligomerisation
and cytochrome c release were absent in these cells. Infected cells turned on pro-survival pathways like cellular Inhibitor of
Apoptosis Protein 2 (cIAP-2) and the Akt/PI3K pathway. Blocking any of these inhibitory pathways sensitized infected host
cell towards apoptosis induction, demonstrating their role in infection-induced apoptosis resistance. Our data support the
hypothesis of evolutionary conserved signaling pathways to apoptosis resistance as common denominators in the order
Chlamydiales.
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Introduction
Simkania negevensis (Sn) is a Chlamydia-like organism [1] belonging
to the family Simkaniaceae, order Chlamydiales [2]. They are obligate
intracellular gram-negative bacteria which replicate within endo-
cytic vacuoles of eukaryotic cells i.e. amoebae, human epithelial
cells and macrophages [3]. Simkania has been reported as an
emerging pathogen associated with several types of respiratory
tract infection such as bronchiolitis in infants [4,5,6,7], community
acquired pneumonia [8,9,10], chronic obstructive pulmonary
disease in adults [11] and acute rejection in lung transplant
recipients [12]. Moreover, seroprevalence rates in adults between
46–80% suggest a broad distribution of the organism in human
populations [13].
Simkania replicates in a biphasic life cycle similar to Chlamydia.
Infection starts with an electron dense elementary body which
differentiates into the electron lucent replicative form called the
reticulate body. The active replication cycle of Sn takes about 3–5
days and extensive long term relationship with the host cell of
about 10–15 days has been reported [14]. The strategy that this
pathogen takes to keep its host alive for such a long period of time
is unknown.
Over the past two decades, a substantial body of evidence has
pointed out the importance of apoptosis, a form of programmed
cell death as an evolutionary conserved strategy for host defense
against bacterial and viral infections [15]. Pathogens in response
utilize idiosyncratic mechanisms to modulate host cell apoptotic
pathways [16]. Neisseria gonorrhoeae and Staphylococcus aureus induce
apoptosis in non-phagocytic host cells [17,18] while bacteria like
Salmonella spp. and Shigella flexneri trigger cell death in host
macrophages [19,20]. Destruction of epithelia and/or depletion
of immune cells, respectively, may help the pathogen to invade
and spread out to deeper tissues of an infected host. Induction of
apoptosis by Chlamydia and Parachlamydia has also been observed
[21,22], however, it is generally accepted and experimentally
verified, that obligate intracellular pathogens like Chlamydia and
Rickettsia confer resistance to apoptosis induced by infection stress
or by external stimuli [23,24]. This serves as a pathogenic strategy
evolved to promote a long-term relationship to complete the
replication cycle and survival in the host cell.
Induction of apoptosis involves a cascade of molecular events
organized in two major pathways: the extrinsic or the death
receptor pathway and the intrinsic or mitochondrial pathway. The
main effectors in both the pathways are a family of cysteinyl
aspartate directed proteases (caspases) that cleave a wide range of
cellular death substrates which ultimately results in apoptotic cell
death [25]. Whereas the extrinsic pathway is initiated by ligand-
dependent activation of cell death receptors, diverse stimuli like
anticancer drugs or cellular stress trigger the intrinsic pathway.
Mitochondria are the central regulators of intrinsic apoptotic
pathways by integrating diverse pro- and antiapoptotic signals.
Apoptotic signals initiate the opening of the outer mitochondrial
membrane (OMM) and the release of caspase-activating molecules
like cytochrome c into the cytoplasm [26]. The family of Bcl-2
proteins plays a pivotal role in controlling the integrity of the
OMM. The so-called BH3-only proteins subfamily are stress
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proteins and the formation of pores in the OMM. Inhibitory Bcl-2
family members like Bcl-2 and Mcl-1 keep Bak and Bax in their
monomeric inactive form and thereby prevent cytochrome c
release and apoptosis induction [27,28].
The activity of caspases can be fine tuned by the direct binding
of X-linked inhibitor of apoptosis protein (XIAP) [29,30]. XIAP and
other members of the inhibitor of apoptosis (IAP) family like cIAP-1
and cIAP-2 possess E3-ligase activity involved in controlling the
stability of apoptosis regulatory pathways [31]. The phosphoino-
sitide 3-kinase (PI3K)-mediated activation of protein kinase B (Akt)
and Raf-MEK-ERK MAP-kinase pathway have emerged as an
important pathway involved in regulating the signaling of cell
proliferation, survival and anti-apoptosis [32,33,34]. These path-
ways control apoptosis not only at the transcriptional, but also at
the post translational level. For example, Raf and Akt inactivate
Bcl-2-associated death promoter (Bad), a BH3 only pro-apoptotic
protein by phosphorylation [35,36].
The mechanism underlying apoptosis resistance of cells infected
with C. trachomatis and C. pneumoniae have been intensively
investigated (for review see [37]). Chlamydia-infected cells are
protected against a wide variety of cell death inducers including
death receptor agonists, anticancer drugs, and double-stranded
RNA reflecting virus-induces cell death [23,38,39,40,41]. Chla-
mydia infection induces the induction and/or stabilization of cIAP-
1, cIAP-2, XIAP and Mcl-1 [41,42,43,44]. Moreover, BH3-only
family members have been demonstrated to be degraded [45,46]
or recruited to inclusions [47] in infected cells. Most of these
studies came to the conclusion, that infection blocks apoptosis at or
upstream of the mitochondria.
This study focuses on the evolutionary conservation of cell death
inhibition among members of Chlamydiales. We found that Sn-
infected cells strongly resist apoptosis induced by various external
stimuli. Pathways subverted in Sn-infected cells to prevent
apoptosis were similar, but not identical to those modulated by
Chlamydia or Chlamydophila. Our data suggest an evolutionary
conservation of mechanism underlying apoptosis regulation in
distantly related members of the order Chlamydiales.
Results
S. negevensis infected cells are resistant to apoptosis
Apoptosis resistance is a hallmark of Chlamydia and Chlamydophila
infection but has so far not been investigated for other family level
related bacteria like Simkania negevensis. To test whether Simkania
confers apoptosis resistance during infection, we induced apoptosis
with tumor necrosis factor alpha (TNF-a) in the presence of
cycloheximide (TNF/Chx) in infected and non-infected HeLa cells.
The cells were fixed and stained with Hoechst 33258 to detect
chromatin condensation (Figure S1) and apoptotic cells were in
addition quantified by terminal transferase mediated dUTP nick
end labeling (TUNEL). A nearly complete block of apoptosis
induced by TNF-a was observed at day 3 post infection (p.i.)
(Figure 1A, S1) illustrated by a reduction in the number of apoptotic
cells from ,60% to ,10% in infected cells (Figure 1B). These
results suggested an anti-apoptotic activity in cells infected with
Simkania. Time course experiments showed time-dependent resis-
tance for TNF/Chx-induced apoptosis at a multiplicity of infection
(MOI) of 0.5 beginning at day 1 p.i. and was similar to non-treated
cells at day 3 with ,10% apoptotic cells (Figure 2A, B). Further,
apoptosis resistance was found to be dependent on the MOI; cells
infected with higher MOI acquired apoptosis resistance much faster
as demonstrated in a quantification of TNF/Chx-induced apoptosis
at day 1 using MOIs ranging from 0.5 to 20 (Figure 2C).
Since the massive infection may directly affect signaling via the
tumor necrosis factor receptor 1 (TNFR1), we determine general
signaling of this receptor during infection by stimulation with
TNF-a in the absence of Chx. This treatment resulted in
phosphorylation of MEK and ERK [48] in both non-infected as
well as infected cells (Figure S2), demonstrating intact TNFR1
signaling.
To test whether the intrinsic apoptosis pathway is inhibited,
Simkania-infected cells were treated with the broad range kinase
inhibitor Staurosporine (STS). Infection reduced the apoptotic
population in STS-treated cells in the same manner as observed in
TNF/Chx-treated cells (Figure 2D). Taken together, S.negevensis
inhibits both TNF/Chx and STS-induced apoptosis in a time and
infection dose-dependent manner.
Caspases are inhibited in Simkania-infected cells
TNF-a-induced apoptosis depends on a well characterized
signaling cascade [49] and is thus suited to more precisely define
the block in apoptotic signaling in Simkania-infected cells. To
investigate whether Simkania blocks the proteolytic cleavage and
activation of caspases, infected and TNF/Chx-treated cells were
tested for caspase processing and activity. Both caspase-3 cleavage
and activity were inhibited by Simkania infection (Figure 3A and B).
Immunostaining revealed that the infected cells showed only
,11% of activated caspase-3 against ,35% of the uninfected
induced cells (Figure S3). Caspase-3 cleavage leads to proteolytic
degradation of key proteins such as the nuclear enzyme poly-ADP
ribose polymerase (PARP). We found that PARP degradation was
inhibited in Simkania-infected TNF/Chx-induced cells (Figure 3A),
confirming a strongly reduced caspase-3 activity in infected cells.
We then tested if infection also affects signaling upstream of the
executioner caspase i.e. caspase-9 and caspase-8 processing or
activity, respectively. Interestingly, while caspase-9 processing was
blocked, caspase-8 activity was even increased by infection with
Simkania (Figure 3A and C), demonstrating the selective inhibition
of caspases in cells infected with Simkania.
Simkania infection prevents cytochrome c release and
Bax/Bak activation
Block of caspase-9/-3 in the presence of active caspase-8
is indicative of an apoptosis inhibition at or upstream of the
mitochondria [50]. Mitochondrial cytochrome c is translocated to
the cytosol of cells undergoing apoptosis where it participates in
caspase-9 activation [51]. Hence, we tested if Sn infection can
prevent cytochrome c release from the cells treated with TNF/Chx
induction. While TNF/Chx treatment induced the release of
cytochrome c from mitochondria of uninfected cells, this was not
the case in Simkania-infected cells (Figure 4A, B). Failure to release
cytochrome c indicated incomplete activation of Bax and/or
Bak upon apoptosis induction. Bax, once activated undergoes a
conformational change permitting insertion into the mitochondrial
membranes. First, we excluded that either Bax or Bak are
differentially transcribed during infection (data not shown). We
then tested whether Bax translocation into mitochondria is
affected in Sn-infected cells upon TNF/Chx-induced apoptosis.
Immunostaining confirmed strongly reduced levels of translocated
Bax in infected cells upon apoptosis induction (Figure 4C). Once
activated Bax and Bak form oligomers in the mitochondrial outer
membrane leading to the release of pro-apoptotic factors like
cytochrome c. We tested Bax and Bak oligomerisation via
mitochondria isolation and in vitro cross-linking. Neither Bax nor
Bak were found to form oligomers after TNF-a treatment
in Simkania-infected cells in comparison to non-infected cells
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PLoS ONE | www.plosone.org 2 July 2011 | Volume 6 | Issue 7 | e22528Figure 1. Simkania negevensis infected HeLa cells are resistant to apoptosis induced by TNF-a. (A) HeLa cells with or without Simkania
infection (MOI 1) were treated with 20 ng/ml TNF-a+3 mg/ml Chx or with carrier for 4 hours. Samples were stained with Hoechst (blue) and TUNEL
(green) and viewed under a fluorescent microscope. The infected cells are marked by white asterisk. White arrowheads mark example apoptotic cells.
n=2(B) Bar diagram displaying the quantitative analysis of the experiment shown in Figure 1A. Cells from five random fields were counted under a
406objective and the percentage of apoptotic cells was calculated. Simkania infection significantly decreased the number of apoptotic cells upon
TNF-a stimulation to nearly background levels (n=2, error bars=SE).
doi:10.1371/journal.pone.0022528.g001
Simkania Negevensis Apoptosis Inhibition
PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e22528Figure 2. Apoptosis inhibition by Simkania is a function of time and infection dose and is independent of the stimulus. (A)
Immunofluorescence analysis of the time and dose dependency of Simkania mediated anti-apoptosis. HeLa cells were infected with Simkania for 1–5
days, MOIs 0.5, 5.0, 10 and 20, induced with 20 ng/ml TNF-a+3 mg/ml Chx or with carrier for 4 hours and stained with Draq5 (nuclei+inclusions, blue),
Syto82 (accumulates in Simkania, red) and Phalloidin (actin, green). The infected cells are marked by white asterisk. Images shown are from an
experiment with MOI 0.5; MOIs 5, 10 and 20 are not shown. Apoptotic cells are marked by white arrowheads. Infection led to apoptosis resistance
from day 1 on. n=3 (B) Bar diagram displaying the quantitative analysis of the time dependency at MOI 0.5 from the experiment shown in Figure 2A.
Cells from five random fields were counted under a 406 objective and the percentage of apoptotic cells was calculated. Apoptosis resistance
increased till day 3; towards the end of the infection cycle apoptosis sensitivity slightly increased until day 5. At higher MOIs infected cells became
more susceptible to apoptosis towards end cycle (data not shown). n=3, error bars=SE (C) Bar diagram displaying the quantitative analysis of the
MOI dependency at day 1 from the experiment shown in Figure 2A. Quantification as described in Figure 2B. Apoptosis resistance was found to be
clearly dose dependent, increasing to MOI 10. At MOI 20 increased apoptosis sensitivity was observed. n=3, error bars=SD (D) Bar diagram
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the mitochondria as well as Bax/Bak oligomerisation.
Bcl-2 family proteins are not differentially regulated in
Simkania infection
Resistance of apoptotic signaling upstream of mitochondria has
previously been shown to involve Bcl-2 family members in
Chlamydia-infected cells. One mechanism involves the degradation
of pro-apoptotic BH3-only proteins acting to either directly or
indirectly induce Bak and/or Bax oligomerisation and mitochon-
drial outer membrane permeabilization [46,52]. We tested
whether this is similar in Simkania infection but could not detect
any degradation of the BH3-only proteins Bad, Bid, Puma,
Bim and Bmf (Figure S4). We also tested for the up-regulation of
anti-apoptotic Bcl-2 family members Bcl-2 and Mcl-1, as the latter
has previously been found to be up-regulated and stabilized in C.
trachomatis infection [41,42]. Interestingly, Mcl-1 and Bcl-2 levels
remained constant in a time course infection experiment
(Figure 5A), indicating that regulation of these Bcl-2 family
members does not account for the apoptosis resistance in Simkania
infection.
Akt is activated and necessary for Simkania-induced
apoptosis resistance
To further determine the origin of Simkania-mediated anti-
apoptosis we tested the major survival pathway directly involved in
TNFR signaling. We first tested activation of the serine/threonine
kinase Akt that promotes survival by phosphorylating and
displaying the quantitative analysis of an infection/apoptosis induction experiment using either TNF-a or STS. HeLa cells with or without Simkania
infection (MOI 0.5) were treated with 20 ng/ml TNF-a+3 mg/ml Chx, STS 1 mg/ml or with carrier for 4 hours. Samples were stained with Hoechst 33258
(images not shown), five random fields were counted under a 406objective and percentage of apoptotic cells was calculated. Simkania infection
significantly decreased the number of apoptotic cells upon TNF-a or STS stimulation (n=2, error bars=SE).
doi:10.1371/journal.pone.0022528.g002
Figure 3. Differential caspase activation during Simkania infection. HeLa cells with or without Simkania infection (MOI 0.5, 3 days) were
treated with 20 ng/ml TNF-a+3 mg/ml Chx for 4 hours before analysis. (A) Immunoblot showing the activation status of caspases-3, -8 and -9 (grey
arrowheads) as well as PARP (black arrowheads) cleavage. Caspase-9 and -3 were not found to be cleaved in infected cells compared to uninfected
induced cells. PARP is also not cleaved nor activated on induction in Simkania infected cells. Actin (white arrowhead) is used as the loading control.
n=2(B) Immunofluorescence analysis showing that caspase-3 is not activated in Simkania infected cells on induction with TNF-a. Nuclei and bacteria
were stained with Draq5 (blue) and activated caspase-3 was detected with an antibody specific for the cleaved protease (green, CL-Caspase 3).
Infected cells are marked by white asterisk, white arrowheads mark active caspase-3. Bacterial inclusions are exemplified by yellow open and nuclei
by red filled circles. n=2 (C) Bar diagram showing the result of a caspase-8 activity assay (caspase-8 glo). Activation of caspase-8 is not blocked by
Simkania infection. n=3, error bars=SE.
doi:10.1371/journal.pone.0022528.g003
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PLoS ONE | www.plosone.org 5 July 2011 | Volume 6 | Issue 7 | e22528Figure 4. Bax/Bak activation and cytochrome c release. (A) Immunofluorescence staining of the effect of Simkania infection on cytochrome c
distribution. HeLa cells with or without Simkania infection (MOI 1, 3 days) were treated with 20 ng/ml TNF-a+3 mg/ml Chx or carrier for 4 hours
before analysis. Cells were stained for cytochrome c (green), Simkania/nuclei (blue) and viewed with a confocal microscope. Upon apoptosis
induction cytochrome c is released from the mitochondria (uninfected+TNF-a), this was not the case for infected cells (infected+TNF-a). The infected
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FoxO3a [35]. In a time course infection experiment we observed
that Akt was indeed strongly phosphorylated in infected cells
(Figure 5A).
To test whether activation of Akt is required for apoptosis
inhibition, inhibitor experiments were performed. The Akt path-
way was investigated by blocking the upstream activator
phosphatidylinositol 3-kinase (PI3K) using LY-294002 [53].
Treatment of infected HeLa cells (day 3 p.i., MOI 1) with LY-
294002 before induction of apoptosis resulted in a marked dose-
dependent apoptosis sensitization (Figure 5B–D) as judged from
PARP cleavage and apoptotic cell count. These results show that
the activity of Akt is required in Simkania-infected cells to resist
apoptosis induction.
cIAPs are up-regulated and required for apoptosis
resistance in Sn-infected cells
We have previously reported that IAPs play a vital role in
apoptosis inhibition of C. pneumoniae- and C. trachomatis-infected
cells [43,44]. Hence, we tested for the regulation of IAPs in Sn
infected cells. Interestingly, we found that cIAP-1 and cIAP-2 were
up-regulated in the course of infection (Figure 6A). We therefore
tested if these IAPs are required to maintain the high apoptosis
resistance in infected cells. Expression of cIAP-1 and cIAP-2 was
silenced in control and infected cells using specific siRNAs and
induced with TNF/Chx for apoptosis. The infected cells were
found sensitized for apoptosis in the absence of cIAP-1 and cIAP-2
(Figure 6B–D), supporting their role in blocking apoptosis in
infected cells.
Discussion
Apoptosis resistance has been a common denominator as an
outcome of infection with and a likely prerequisite for the
development of obligate intracellular pathogenic Chlamydia. Here,
we have demonstrated that the evolutionary related bacterium
Simkania negevensis is also able to block host apoptosis. We provide
evidence that anti-apoptotic and survival mechanisms are widely
conserved over the order Chlamydiales. An exception to this rule
may be Parachlamydia which appears to survive in human
macrophages but eventually triggers apoptosis [22]. The inability
to induce apoptosis inhibition may be one reason why Para-
chlamydia does not replicate in most mammalian cell types [54].
It is still unclear whether Simkania and Parachlamydia are able to
influence death of Amoebae. Signaling to cell death inhibition
initially could have co-evolved as a consequence of the Simkania -
Amoebae interaction and could have later been exploited during the
exposure to mammalian cells. Adaptation to different hosts may, at
least in part, explain the differences we observed in anti-apoptotic
signaling between cells infected with members of Chlamydiales
adapted to Amoebae (Simkania) and mammalian cells (C. trachomatis,
C. pneumoniae).
It has previously been suggested that apoptosis inhibition
depends on the developmental cycle of Chlamydia with the onset
early after EB to RB transition and maximum during RB
replication [23]. The developmental cycle of Simkania lasts up to
10 days and therefore significantly longer than that of C. trachomatis
(48 h) and C. pneumoniae (72–96 h) under comparable infection
conditions. It was therefore unexpected to see that even at an MOI
of 0.5, conditions, where one EB infects one cell, about 50% of the
cells were protected from apoptotic stimuli already at 24 h p.i. and
all infected cells were completely protected at three days p.i. A
similar efficient protection at such low MOI has neither been
observed with C. trachomatis [23] nor with C. pneumoniae [39,40].
The infected cell remained resistant for apoptotic stimuli up to day
4 p.i. indicating that Simkania has evolved highly efficient and
long-lasting mechanisms to block host cell death. Similar to C.
trachomatis infection, cells infected at higher MOI acquired apo-
ptosis resistance earlier (Figure 2C) which has been suggested to be
dependent on the rapid entry of the bacteria into the replicative
phase of the developmental cycle [23]. Interestingly, similar as
with C. trachomatis, infection with Simkania at a higher MOI up to
100 had no visible cytotoxic effect (KK and TR, unpublished),
whereas significant cytotoxicity already starting at an MOI of 10
has been reported for C. pneumoniae infection [40]. Different to
what has been reported for C. trachomatis infected Mccoy cells, Sn
did not induce apoptosis in neighboring uninfected cells during
any stage of the infection, excluding paracrine apoptosis induction
[21].
Despite differences in the kinetics of the onset, efficiency and
duration of apoptosis resistance, all our data demonstrate a block
in apoptotic signaling upstream or at the mitochondria. The
mechanism underlying apoptosis resistance in Simkania-infected
cells may thus be very similar to those in cells infected with C.
trachomatis and C. pneumoniae, in which apoptotic signaling via
mitochondria is prevented [38,42]. Neither Bak nor Bax were
found activated in Sn-infected cell treated with TNF/Chx and
cytochrome c was fully retained in the mitochondria of these cells.
Similar as we have found for C. trachomatis-infected cells [42], this
complete and strong block of apoptotic signaling was maintained
in the infected cell despite of unchanged levels of BH3-only
proteins. In contrast, others have found degradation of BH3-only
proteins in cells infected with C. trachomatis [45,46], indicating that
depletion of BH3-only proteins plays a role in blocking apoptosis
upstream of the mitochondria in their infection setting.
We currently do not know how mitochondrial signaling is
blocked in Sn-infected cells. Unlike in C. trachomatis infection [42],
Mcl-1 as one of the major inhibitors of Bak and Bax activation was
neither up-regulated nor stabilized in Sn-infected cells. Also the
levels of Bcl-2 remained unchanged in the course of Sn infection
(Figure 5A).
The data presented here and our previously published work
demonstrates that IAPs play a major role in maintaining apoptosis
resistance in cultured cells infected with Simkania, C. trachomatis and
cells are marked by white asterisk, n=2 (B) Western blot analysis for cytochrome c release. Cytosol and mitochondria were isolated as described in
the experimental procedures section and cytochrome c was detected by Western blot. Cytochrome c release was completely blocked by Simkania
infection. Tom40 was used as a marker for mitochondria and Actin as a marker for cytosol. (C) Immunofluorescence staining of active Bax with a
conformation sensitive antibody [65] after Simkania infection. HeLa cells were treated as described in Figure 4A. Images show mitochondrial
localization of active Bax (green) in control-induced cells. Bax was not activated in TNF treated Simkania infected cells. The infected cells are marked
by white asterisk. n=2 (D) Immunoblot analysis of Bax and Bak after mitochondrial isolation and in vitro cross linking. HeLa cells with or without
Simkania infection (MOI 1, 3 days) were treated with 20 ng/ml TNF-a+3 mg/ml Chx or carrier for 4 hours before mitochondria isolation, in vitro cross
linking and analysis. Bax and Bak (black arrows) are not activated in Simkania infected induced cells as shown by background Bax and Bak
oligomerisation (brackets). Equal loading was verified by Bradford assay and Tom40 western blot. Input Bak, Bax and Actin showed no differences in
expression or loading. n=2.
doi:10.1371/journal.pone.0022528.g004
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PLoS ONE | www.plosone.org 7 July 2011 | Volume 6 | Issue 7 | e22528Figure 5. Regulation of Bcl-2 family members and PI3 kinase signaling during Simkania infection. (A) Immunoblot analysis of the anti-
apoptotic/pro-survival signaling during Simkania infection. HeLa cells were infected with Simkania or Mock (control) in a time course experiment
before analysis. Anti-apoptotic Bcl-2 family members like Mcl-1 or Bcl-2 (grey arrowheads) are not regulated. Akt is strongly activated during infection
(black arrowheads). Hsp-60 and Actin (white arrowheads) were used as loading controls. n=2. (B) Immunoblot analysis of PARP cleavage in Simkania
infected cells after treatment with PI3K inhibitor. Simkania infected HeLa 229 cells were treated with Ly294002 (PI3 kinase Inhibitor) on day 3 post
infection for 6 hours and induced with 20 ng/ml TNF-a+3 mg/ml Chx or carrier for 4 hours before analysis. PARP cleavage (black arrowheads) was a
measure of apoptosis sensitization. Treatment with 0.1 mM LY29004 clearly sensitized infected cells to apoptosis. Hsp-60 and Actin (white arrowhead)
were used as loading controls. n=2. (C) Bar diagram showing samples treated similar as in Figure 5B but prepared for immunofluorescence analysis.
Hoechst stained cells were counted to determine the number of apoptotic cells (406magnification, five fields per sample, n=2, Error bars=SE). 1 mM
LY29004 was found to restore apoptosis sensitivity to ,70% of control (D) Immunofluorescence of samples treated as described in Figure 5B–C.
Samples were stained with Hoechst (blue) and viewed under a fluorescent microscope for counting. Hoechst dye stained both HeLa cell nuclei and
Simkania inclusions (yellow mark). White arrowheads mark example apoptotic cells. n=2.
doi:10.1371/journal.pone.0022528.g005
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PLoS ONE | www.plosone.org 8 July 2011 | Volume 6 | Issue 7 | e22528Figure 6. cIAPs are upregulated on Simkania infection and are required for the resistance of apoptosis. (A) Immunoblot analysis of the
anti-apoptotic/pro-survival apoptosis regulators during Simkania infection. HeLa cells were infected with Simkania or Mock (control) (MOI 1) in a time
course experiment before analysis. Anti-apoptotic cIAP-1 and -2 (black arrowheads) are strongly upregulated. Hsp-60 and Actin (white arrowheads)
were used as loading controls. n=2. (B) Immunoblot confirmation of cIAP-1 and -2 knockdown. HeLa cells were transfected with siRNA directed
against cIAP-1, -2 or Luciferase (control). cIAP-1 and -2 (black arrowheads) were strongly down regulated at day 3 post transfection. Actin (white
arrowheads) was used as loading control. n=2. (C) Immunoblot analysis of PARP cleavage in Simkania infected cells after cIAP-1 and -2 single or cIAP-
1/-2 double knockdown. HeLa 229 cells were transfected for 3 days before Simkania infection. On day 3 post infection cells were induced with 20 ng/
ml TNF-a+3 mg/ml Chx or carrier for 4 hours before analysis. PARP cleavage (black arrowheads) was a measure of apoptosis sensitization. Single
knockdown of either cIAP-1 or -2 or both clearly sensitized infected cells to apoptosis. Actin (white arrowhead) was used as loading control. n=2. (D)
Bar diagram showing samples treated similar as in Figure 6C but prepared for immunofluorescence analysis. Hoechst stained cells were counted to
determine the number of apoptotic cells (406magnification, five fields per sample, n=2, Error bars=SE). Single knockdown of either cIAP-1 or -2 or
both was found to restore apoptosis sensitivity to ,70% of control.
doi:10.1371/journal.pone.0022528.g006
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nary infection experiments with C. pneumoniae in knockout mice
suggest an important function of cIAP-1 in innate immune
signaling in macrophages [55]. A role of IAPs in innate immune
signaling is consistent with recent reports demonstrating a role of
both, cIAP-1 and cIAP-2 in innate immune signaling rather than
in directly inhibiting caspase activation [31]. Infection may
directly influence IAP stability as these proteins possess E3 ligase
activity and control their own stability and the stability of other
IAPs [56]. In this context the previous description of IAP-IAP
hetero complexes implemented in IAP stabilization in C.
trachomatis-infected cells may also be relevant for Simkania infection
[43].
As previously described for C. trachomatis [47] and C. pneumoniae
[57] infection, Simkania infection strongly activates the PI3K-Akt
pathway. Activated Akt promotes cell survival through crosstalk
with other signaling cascades like the NF-kB pathway [58]. Akt
has in addition a role in cell survival by increasing the uptake of
nutrients, positive regulation of metabolic pathways and mainte-
nance of mitochondrial membrane potential [59]. There is also a
direct link between Akt and cell survival by phosphorylating and
inhibiting the function of pro-apoptotic Bad [60]. We could not
observe, however, any changes in the Akt-specific phosphorylation
of sites S116 and S136 in Bad in the course of Simkania infection
(KK and TR, unpublished), as has previously been described for
C. trachomatis infection [47]. The observation that PI3K inhibitors
sensitize cells infected with C. trachomatis [42] or Simkania to
apoptosis speaks in favor for an evolutionary conserved role of this
central survival pathway in controlling host cell survival during
development and replication of Chlamydiales in their mammalian
hosts.
Activation of Akt can favor high expression of cIAP-1 [61],
consistent with elevated levels of IAPs and increased phosphor-
ylation of Akt during the course of infection until day 5. This raises
the questions how these long-term signaling events are fueled even
several days after the first interaction of the pathogen with the host
cell. One could speculate that the bacterial factors play a crucial
role in manipulating the host. Like other pathogenic members of
the Chlamydiales, Simkania has been reported to have a type III
secretion system which may help to transport proteins across the
inclusion membrane into the cytosol of the host [62]. Secreted
bacterial proteins may take over the pacemaker function in
maintaining the host cell in a survival mode to guarantee such a
long term host pathogen relation.
Materials and Methods
Cell culture, propagation of Simkania negevensis
HeLa 229 cells (CCL-2.1) obtained from ATCC were grown
in DMEM supplemented with 10% fetal calf serum (FCS).
For propagation of Simkania, HeLa 229 cells were grown in
DMEM medium supplemented with 5% FCS, 2 mM L-glutamine,
10000 U/ml penicillin, 10 mg/ml streptomycin, 8 mg/ml genta-
micin and 50 mg/ml vancomycin [63] and 1 mg/ml Chx. Bacterial
purification was done as described [64] with the exception that
Simkania was harvested on day 5 post infection.
Antibodies, counter stains and chemicals
Chemicals were obtained from Sigma-Aldrich unless other-
wise indicated. Rabbit polyclonal anti-human active Caspase-3,
Caspase-9, Bid, ERK, MEK, p-ERK and p-MEK were from Cell
Signaling Technology. Mouse monoclonal anti-human PARP,
cytochrome c, cIAP-2, cIAP-1, BAX (clone 6A7) and mouse
monoclonal anti-Chlamydia Hsp60 were purchased from Santa
Cruz Technology. Mouse monoclonal anti-human b-Actin
was from Sigma Aldrich. Mouse anti-human BAK (Ab-1) was
obtained from Oncogene Research Products. Secondary antibod-
ies were horseradish peroxidase-labelled rabbit anti-mouse or anti-
rabbit antibodies from Amersham Biosciencesor Cy2, Cy3 or Cy5
- labeled anti-mouse or anti rabbit antibodies from Dianova,
Immunodiagnostic. Syto82, Draq5 and Hoechst 33258 were
obtained from Invitrogen (Molecular probes), Alexis and Sigma-
Aldrich, respectively.
Apoptosis induction
Infected and control cells were induced for apoptosis with
20 ng/ml of human recombinant TNF-a (BD Pharmingen, San
Diego, California) with 3 mg/ml of Chx for 4 h or with 1 mM STS
for 5 h. The control cells were incubated with Chx. After the
respective time post induction, the stimulated and control cells
were fixed with 4% paraformaldehyde for 20 min for immuno-
staining or harvested using lysis buffer (4% SDS, 20% glycerol,
10% 2-mercaptoethanol, 0.004% bromphenol blue, 0.125 M Tris
HCl) and analyzed by western blotting.
Immunofluorescence analysis
For immunofluorescence analysis, cells were seeded on glass
coverslips (Marienfeld Laboratory glassware, Germany) of 15 mm
diameter and then infected or treated as uninfected controls. The
cells were treated appropriately for the concerned experiment and
washed in phosphate-buffered saline (PBS) and fixed with 4%
paraformaldehyde in PBS for 20 min. After washing, the cells
were permeabilized using 0.2% Triton-X100 in PBS for 20 min
and blocked with 2% FCS in PBS for 45 min. Cells were
incubated for 1 hour with the respective primary antibody at
1:50–1:100 dilution in blocking buffer (2% FCS in PBS), washed
three times in PBS, and stained with the corresponding secondary
antibody. For counter staining cells were treated with Hoechst
33258 (5 mg/ml) or Draq5 for 30 min at room temperature to
detect nuclei and intracellular bacteria. After washing three times
with PBS, samples were mounted onto slides using Mowiol 4–88
(Carl Roth, Germany). Samples were analyzed on either a Leica
DMR epifluorescence or Leica SPE confocal microscope. For
apoptosis assays cells from five random 406 magnification fields
were counted. The percentage of apoptotic cells was calculated as
number of apoptotic cells/number of total cells. Terminal
deoxynucleotidyltransferase-mediated nick-end labelling (TUNEL)
assays were performed according to manufacturer’s instructions
(Promega, Madison.) and were analyzed as previously described
[64].
Detection of Caspase-8 activation
HeLa 229 cells were seeded in 96 well plates at a concentration
of 15000 cells/ml. Cells were infected with Sn and after 3 days of
infection the cells were apoptosis induced with TNF/Chx as
described above. The assay was performed using caspase glo-
8-assay (Promega) according to the manufacturer’s instructions
and was analyzed using a Infinite M200 multiplate reader (Tecan).
Immunoblotting and in vitro cross-linking of proteins
Cell monolayers were collected and lysed with sample buffer
(3% 2-mercaptoethanol, 20% glycerine, 0.05% bromophenol blue
and 3% SDS) and boiled at 90uC for 5 min. Immunoblotting was
performed as previously described [64]. For in vitro cross-linking of
proteins, HeLa 229 cells were grown in 35 cm
2 plates to 60–70%
confluency. Apoptosis was induced as described in the apoptosis
induction section or mock induced in the presence of 3 mg/ml
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scraped with a rubber police and washed in PBS by centrifugation
at 1000 rpm for 3 min at 4uC. For mitochondrial isolation, the
pellet was resuspended in Buffer A (20 mM Hepes pH 7.6,
220 mM mannitol, 70 mM sucrose, 1 mM EDTA, 0.5 mM
PMSF and 2 mg/ml BSA) and left on ice for 15 min. Cells were
lysed with a homogenizer and pelleted at 800 g for 5 min at 4uC.
Mitochondria containing supernatant was collected and centri-
fuged again at 10.000 g for 10 min at 4uC. Mitochondrial pellet
was resuspended in Buffer B (Buffer A without BSA), quantified
using a Nanodrop (Peqlab, Germany) and stored at 280uC.
Supernatant containing cytoplasmic proteins was kept in cyto-
chrome c release assays. 60 mg mitochondria were pelleted
(10.000 g, 10 min, 4uC) and washed once with SET-buffer
(250 mM sucrose, 10 mM Tris/Hcl pH 7.6, 1 mM EDTA) and
resupended in 95 ml SET-buffer. Cross linking was done with
BMH (Pierce, Rockford) at a final concentration of 1 mM for
30 min at room temperature. For quenching of the cross linker
2 ml DTT (2.5 mM) were added and samples were incubated for
5–10 min on ice. Cross linked mitochondria were pelleted
(14.000 rpm, 5 min, 4uC) and washed once in SET-buffer,
resuspended in 30 ml Laemmli-buffer and analyzed by western
blotting.
siRNA transfection
HeLa 229 cells were seeded in 12-well plates one day before
transfection. siRNA was transfected using Lipofectamine 2000
(Invitrogen) according to manufacturer’s instructions. Six hours
post transfection medium was exchanged and 24 hours post
transfection cells were infected with Sn (MOI 1) for 3 days before
apoptosis induction with TNF-a. Knockdown was confirmed via
immunoblotting. The following siRNAs were used in the study:
siLuc (Control): AACUUACGCUGAGUACUUCGA, sicIAP-1: AA-
CAUAGUAGCUUGUUCAGUG, sicIAP-1 CUAGGAGACAGUCCUA-
UUCAA, sicIAP-2: AAUUGGGAACCGAAGGAUAAU, sicIAP-2 TT-
CAAGAUACACAGUUU CUAA. The respective two siRNAs
were used as a pool.
Statistical analysis
For statistical calculations and histograms Excel (Microsoft) was
used. Statistical significance was calculated using the students T
test.
Supporting Information
Figure S1 Sn infected cells block the TNF-a induced
apoptosis in HeLa cells. HeLa cells with or without Simkania
infection (MOI 1) were treated with 20 ng/ml TNF-a+3 mg/ml
Chx or with carrier for 4 hours. Samples were stained with
Hoechst (blue) and viewed under a fluorescent microscope.
Hoechst dye stained both HeLa cell nuclei and Simkania inclusions.
The infected cells are marked by white asterisk. Uninfected cells
show apoptotic cells which are bright spots due to nuclear
condensation. Infected induced cells show a clear block of
apoptosis. n=2.
(TIF)
Figure S2 TNF receptor is activated in Simkania
infected cells. HeLa cells with or without Simkania infection
(MOI 1) were treated with 20 ng/ml TNF-a without Chx for 5,
15, 30 and 60 minutes to activate the MEK-ERK pathway. The
figure shows the phosphorylation of MEK (grey arrowheads) and
ERK (white arrowheads), indicating that the TNF receptor is
active. Actin is used as the loading control. n=2.
(TIF)
Figure S3 Sn infected cells block the activation of
caspase-3. Bar diagram displaying the quantitative analysis of
the caspase-3 activation at MOI 0.5 from the experiment shown in
figure 3B. Cells from five random fields were counted under a 406
objective and the percentage of caspase-3 positive cells was
calculated. Simkania infection strongly reduced caspase-3 activa-
tion. n=3, error bars=SE.
(TIF)
Figure S4 Pro-apoptotic BH3 only Bcl-2 family mem-
bers are not regulated. Immunoblot analysis of the pro-
apoptotic BH3 only Bcl-2 family members during Simkania
infection. HeLa cells were infected with Simkania or Mock (control)
(MOI 1) in a time course experiment before analysis. The BH3
only proteins (Bad, Bid, Puma, Bim, Bmf, black arrowheads) are
not regulated in Simkania infected cells. Hsp-60 and Actin (white
arrowheads) were used as loading controls. n=2.
(TIF)
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